This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hobden, J. A.
Right arrow Articles by Hazlett, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hobden, J. A.
Right arrow Articles by Hazlett, L. D.

 Previous Article  |  Next Article 

Infection and Immunity, February 1999, p. 972-975, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Pseudomonas aeruginosa Keratitis in Knockout Mice Deficient in Intercellular Adhesion Molecule 1

Jeffery A. Hobden,* Sharon Masinick-McClellan, Ronald P. Barrett, Kenneth S. Bark, and Linda D. Hazlett

Department of Anatomy and Cell Biology and Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan 48201

Received 8 June 1998/Returned for modification 17 August 1998/Accepted 23 November 1998


    ABSTRACT
Top
Abstract
Text
References

In this study, the role of intercellular adhesion molecule 1 (ICAM-1) in the pathogenesis of Pseudomonas aeruginosa keratitis was examined by using inbred ICAM-1-deficient knockout mice. These mice had significantly less (P <=  0.02) ocular disease than wild-type mice, suggesting that ICAM-1 contributes to a more severe disease response following P. aeruginosa infection.


    TEXT
Top
Abstract
Text
References

Pseudomonas aeruginosa is capable of causing devastating corneal infections. Several studies suggest that bacterial proteases (2, 6, 15, 16) contribute to the pathogenesis of P. aeruginosa keratitis. The host inflammatory response to P. aeruginosa corneal infection consists primarily of an influx of polymorphonuclear leukocytes (PMN) which also destroy corneal tissue (11, 18), despite their being essential to resolving the infection (7, 9).

PMN migrate from the tear film and from the limbal and iridial vasculature into the avascular cornea. Intercellular adhesion molecule 1 (ICAM-1) is a key molecule for PMN recruitment into infected tissue. Up-regulation of ICAM-1 is correlated with the ability of outbred mice to restore corneal clarity after infection with P. aeruginosa (12). However, immunostaining of inflamed human ocular tissue (1, 4) suggests that ICAM-1 is a key mediator of acute ocular inflammation. The purpose of this study was to clarify the role of ICAM-1 in ocular P. aeruginosa infection.

Breeding pairs of homozygous 129/Sv wild-type (WT) mice and knockout (KO) mice deficient in ICAM-1 expression (21) were supplied by Jose-Carlos Gutierrez-Ramos of the Center for Blood Research, Harvard Medical School (Boston, Mass.). Eight-week-old ICAM-1 KO mice and age- and sex-matched WT mice were used. Mice in this study were treated humanely, in accordance with the ARVO Resolution on the Use of Animals in Research.

The preparation of the bacterial inoculum used in this study to initiate pseudomonal keratitis in mice has been described (13). Briefly, overnight broth cultures of P. aeruginosa ATCC 19660 (American Type Culture Collection, Manassas, Va.) were pelleted by centrifugation, washed once with sterile saline (pH 7.2), and resuspended in saline to a concentration of approximately 2.0 × 1010 CFU/ml. The mouse scratch wound model of P. aeruginosa keratitis also has been previously described (13). Mice were anesthetized, and the corneal surface of the left eye of each animal was wounded with a sterile 26-gauge needle. A 5.0-µl bacterial suspension containing 1.0 × 107 CFU was then delivered topically onto the surface of the wounded cornea.

Mice were macroscopically evaluated in a masked fashion and disease graded with a scale of 0 to +4 (8), with 0 signifying no disease and +4 signifying corneal perforation. The ocular pathology observed at each time point is expressed as the mean clinical score ± standard error of the mean (SEM). Means represent the sum of scores at each time point divided by the number of corneas scored (n >=  10).

Interleukin 1beta (IL-1beta ) and tumor necrosis factor alpha (TNF-alpha ) enhance ICAM-1 expression 5- to 10-fold above constitutive levels on receptive cells in vitro (3). ICAM-1 expression peaks 24 h after induction with these cytokines and remains elevated for another 48 h (5). At 6, 12, 24, and 48 h postinfection (p.i.), ICAM-1-deficient KO mice and WT mice were sacrificed and corneas were processed for quantitation of IL-1beta and TNF-alpha by enzyme-linked immunosorbent assay (ELISA), as described previously (13). Uninfected corneas from five naive KO mice and five WT mice were similarly processed as controls. Cytokine concentrations are expressed as picograms of cytokine per milligram of corneal tissue. The sensitivities of the ELISAs for IL-1beta and TNF-alpha are 10 and 15 pg/ml of sample, respectively. Each cytokine assay was repeated at least twice.

At 6, 12, 24, and 48 h p.i., six ICAM-1-deficient KO mice and six WT mice were sacrificed, and corneas were harvested as described previously (13) for quantitation of viable bacteria (by direct plate count) and of infiltrating PMN (by assay of myeloperoxidase activity [14]). The numbers of viable bacteria in corneas are expressed as mean log CFU of bacteria ± SEM. Infiltrating PMN in corneal tissue are expressed as mean log PMN ± SEM per milligram of cornea.

The procedure for embedding eyes in resin and sectioning for light microscopy has been described before (10). Eyes (n = 3) at each time point were enucleated at 6 and 12 h and at 1, 2, 3, 5, 7, 14, and 21 days p.i., fixed in a 1:1:1 solution of osmium tetroxide, glutaraldehyde, and Sorenson's phosphate buffer (pH 7.4), dehydrated in graded ethanols and propylene oxide, infiltrated with epon-araldite, and embedded. Thick (1.75-µm) sections were cut with an ultramicrotome and stained with Richardson's stain (17) for histopathology.

Eyes (n = 3) from uninfected WT and KO mice were enucleated for determination of constitutive expression of ICAM-1. Eyes (n = 3 [each]) from WT and KO mice infected with P. aeruginosa were enucleated at 48 h p.i. to test for up-regulation of ICAM-1 expression. ICAM-1 immunostaining was performed as described previously (12) except that a Metal Enhanced DAB substrate kit (Pierce, Rockford, Ill.) was used for development of the sections.

Statistical analyses were performed with StatView SE + Graphics, version 4.5 (Abacus Concepts, Inc., Berkeley, Calif.). An unpaired Student's t test using a two-tailed hypothesis was used to test for statistical significance in differences in the numbers of PMN per milligram of cornea, the numbers of viable bacteria per cornea, and the concentrations of cytokines per milligram of cornea. A nonparametric Mann-Whitney U test was used to compare mean clinical scores of infected ICAM-1-deficient KO mice and WT mice. Statistical significance was established at the P <=  0.05 confidence interval.

P. aeruginosa ocular disease in ICAM-1 KO mice and WT mice. The corneal disease responses of ICAM-1-deficient KO mice and WT mice, expressed as mean clinical scores (± SEM), are shown in Fig. 1. At least 10 eyes from each group were examined per time point. At 2 days p.i., ocular pathology was more severe in WT than in ICAM-1-deficient KO mice (P <=  0.02). By 3 days p.i., the difference in disease response between WT and ICAM-1-deficient KO mice was more pronounced (P <=  0.0001). Ocular disease continued to be more severe in WT than in ICAM-1-deficient KO mice through 15 days p.i. (P <=  0.02). By 21 days p.i., eyes of both groups of mice were similar in appearance (P >=  0.6). Uninfected corneas of both groups of mice were similar upon microscopic examination (data not shown). By 6 h p.i., inflammatory cells had localized in conjunctival and iridial blood vessels in both ICAM-1-deficient KO mice and WT mice and were beginning to emigrate into the peripheral cornea and the anterior chamber (Fig. 2A), respectively. With the exception of the epithelial wounds created 6 h earlier and the presence of a few inflammatory cells in the peripheral cornea and the anterior chamber, the corneas of ICAM-1-deficient KO mice and WT mice were morphologically similar to uninfected corneas (Fig. 2A and B).


View larger version (18K):
[in this window]
[in a new window]
 
FIG. 1.   Mean clinical scores (± SEM) of ocular disease responses in ICAM-1-deficient KO mice and WT mice. Means represent the sum of scores at each time point divided by the number of corneas scored (n >=  10). At 1 day p.i., P was >= 0.17; at 2 to 15 days p.i., P was <= 0.02; and at 20 and 21 days p.i., P was >= 0.56.


View larger version (167K):
[in this window]
[in a new window]
 
FIG. 2.   Histopathology of the central region of corneas from WT mice at 6 (A), 24 (C), and 48 (E) h p.i. and from ICAM-1-deficient KO mice at 6 (B), 24 (D) and 48 (F) h p.i. EP, epithelium; ST, stroma; AC, anterior chamber. Small arrowheads indicate inflammatory cell infiltrate in anterior chamber; large arrowheads indicate inflammatory cell infiltrate in corneal stroma. Richardson's stain was used. Magnification (A and B), ×200; magnification (C to F), ×100.

At 12 and 24 h p.i., inflammatory cells had infiltrated the corneas of both ICAM-1-deficient KO mice and WT mice. Although the numbers of inflammatory cells in the corneal stroma and the peripheral corneal epithelium of both groups of mice appeared to be similar, other pathological differences were evident. For example, the corneal epithelium of WT mice was denuded over the central cornea, which was markedly swollen (Fig. 2C). In contrast, the central corneal epithelium of ICAM-1 KO mice was partially intact and the corneal thickness was normal (Fig. 2D). In contrast to ICAM-1-deficient KO mice, there was a significant number of inflammatory cells (too numerous to count) in the anterior chamber of WT mice.

At 48 and 72 h p.i., inflammatory cells continued to infiltrate corneas of ICAM-1-deficient KO mice and WT mice, appearing more dense in the central cornea (Fig. 2E and F). The number of inflammatory cells in the anterior chamber of ICAM-1-deficient KO mice had visibly decreased, whereas inflammatory cells filled the anterior chamber of WT mice. By 5 to 7 days p.i., the number of inflammatory cells in the anterior chamber of ICAM-1-deficient KO mice was diminished while the anterior chamber of WT mice remained infiltrated with inflammatory cells. At 14 days p.i., the cell infiltrate was decreased in both KO and WT mice; however, corneas of WT mice remained swollen. By 21 days p.i., corneas of both KO and WT mice demonstrated some stromal scarring and neovascularization, but no inflammatory cells were seen in the anterior chamber.

Corneal inflammation and infection. No ICAM-1 immunostaining was observed in uninfected or infected eyes of ICAM-1-deficient KO mice (data not shown). In WT mice, ICAM-1 was constitutively expressed (weakly) on stromal keratocytes and corneal epithelium (data not shown). The intensity of immunostaining increased by 48 h after infection with P. aeruginosa in WT mice.

IL-1beta and TNF-alpha were not constitutively expressed in the uninfected corneas of either KO or WT mice. Concentrations of IL-1beta and TNF-alpha in infected corneas are shown in Fig. 3. There were no significant differences (P >=  0.10) in cytokine concentrations in KO and WT infected eyes.


View larger version (34K):
[in this window]
[in a new window]
 
FIG. 3.   Concentrations of TNF-alpha and IL-1beta in corneas of ICAM-1-deficient KO mice and WT mice expressed as picograms of TNF-alpha or IL-1beta per milligram of corneal tissue. No significant differences were observed between the two groups of mice (P >=  0.10).

There were no significant differences in the mean log base 10 numbers of viable bacteria recovered from corneas of KO or WT mice at any time point (P >=  0.29). At 6 h p.i., no myeloperoxidase activity was found in homogenates of corneas from ICAM-1-deficient KO mice (<= 3.0 log PMN). In contrast, approximately 4.8 log PMN/mg of tissue infiltrated the corneas of WT control mice. At 12, 24, and 48 h p.i., there was no significant difference (P >=  0.27) in the numbers of infiltrating PMN per milligram of cornea between KO and WT mice.

ICAM-1 and P. aeruginosa keratitis. The inbred mouse strain 129/Sv is resistant to ocular infection with P. aeruginosa; i.e., mice are able to resolve the infection and restore ocular integrity within 21 days p.i. Mutant mice deficient in ICAM-1 expression are phenotypically similar to WT mice with the exception of the ICAM-1 deficiency and a moderate elevation in the number of circulating PMN, probably resulting from the lack of cell trafficking brought about by the deleted adhesion molecule (21). Cytokine production in ICAM-1-deficient 129/Sv KO mice is unaffected by a lack of ICAM-1 expression. Inflammation-induced serum concentrations of cytokines such as IL-1alpha , IL-6, gamma interferon, and TNF-alpha in ICAM-1 deficient KO mice were shown to be comparable to those of WT animals (19, 21). In the present study, we similarly found no significant differences in corneal cytokine concentrations in WT versus ICAM-1-deficient KO mice after infection with P. aeruginosa.

The adhesion molecule ICAM-1, when up-regulated by proinflammatory cytokines, appears to play a significant role in development of the severe pathology characteristic of P. aeruginosa eye infections, presumably by the recruitment of an overwhelming number of inflammatory cells (PMN) into the anterior chamber from the iris/ciliary body. However, the presence of ICAM-1 does not appear to be critical in recruiting a sufficient number of PMN into the cornea to eliminate the bacteria and resolve the infection. It is also likely that other, as yet undefined, mechanisms are present in ICAM-1-deficient KO mice which compensate for the absence of the adhesion molecule. One likely candidate is intercellular adhesion molecule 2 (ICAM-2). ICAM-2 is constitutively expressed in the ICAM-1 KO mouse on the 129/Sv background (21). The basal expression of ICAM-2 is higher than that of ICAM-1, but, unlike ICAM-1, it is not cytokine inducible (20). Future studies will seek to determine if ICAM-2 or other adhesion molecules compensate for ICAM-1 in P. aeruginosa keratitis.


    ACKNOWLEDGMENTS

These studies were supported by NEI R29 EY11483 (J.A.H.) and NEI R01 EY02986 (L.D.H.) and in part by P30 EY04068 (L.D.H.), from the National Eye Institute, National Institutes of Health.


    FOOTNOTES

* Corresponding author. Mailing address: Wayne State University School of Medicine, Department of Immunology and Microbiology, 540 E. Canfield Ave., Detroit, MI 48201. Phone: (313) 577-9746. Fax: (313) 577-1155. E-mail: jhobden{at}med.wayne.edu.

Editor:   R. N. Moore


    REFERENCES
Top
Abstract
Text
References

1. El-Asrar, A. M. A., K. Geboes, S. Al-Kharashi, K. F. Tabbara, L. Missotten, and V. Desmet. 1997. Adhesion molecules in vernal keratoconjunctivitis. Br. J. Ophthalmol. 81:1099-1106[Abstract/Free Full Text].
2. Engel, L. S., J. A. Hobden, J. M. Moreau, M. C. Callegan, J. M. Hill, and R. J. O'Callaghan. 1997. Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Investig. Ophthalmol. Vis. Sci. 38:1535-1542[Abstract/Free Full Text].
3. Figdor, G. C., and Y. van Kooyk. 1992. Regulation of cell adhesion, p. 151-182. In J. M. Harlan, and D. Y. Liu (ed.), Adhesion, its role in inflammatory disease. W. H. Freeman & Co., New York, N.Y.
4. Goldberg, M. F., T. A. Ferguson, and J. S. Pepose. 1994. Detection of cellular adhesion molecules in inflamed human corneas. Ophthalmology 101:161-168[Medline].
5. Granger, D. N., and P. Kubes. 1994. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J. Leukoc. Biol. 55:662-675[Abstract].
6. Gupta, S. K., S. A. Masinick, J. A. Hobden, R. S. Berk, and L. D. Hazlett. 1996. Bacterial proteases and adherence of Pseudomonas aeruginosa to mouse corneas. Exp. Eye Res. 62:641-650[Medline].
7. Hazlett, L. D., and R. S. Berk. 1977. Pseudomonas eye infections in cyclophosphamide-treated mice. Investig. Ophthalmol. Vis. Sci. 16:649-652[Abstract/Free Full Text].
8. Hazlett, L. D., M. M. Moon, M. Strejc, and R. S. Berk. 1987. Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Investig. Ophthalmol. Vis. Sci. 28:1978-1985[Abstract/Free Full Text].
9. Hazlett, L. D., D. D. Rosen, and R. S. Berk. 1977. Experimental Pseudomonas keratitis in immunosuppressed hybrid mice. Ophthalmic Res. 9:374-380.
10. Hazlett, L. D., M. Zucker, and R. S. Berk. 1992. Distribution and kinetics of the inflammatory cell response to ocular challenge with Pseudomonas aeruginosa in susceptible versus resistant mice. Ophthalmic Res. 24:32-39[Medline].
11. Hobden, J. A., L. S. Engel, M. C. Callegan, J. M. Hill, B. M. Gebhardt, and R. J. O'Callaghan. 1993. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr. Eye Res. 12:461-467[Medline].
12. Hobden, J. A., S. A. Masinick, R. P. Barrett, and L. D. Hazlett. 1995. Aged mice fail to up-regulate ICAM-1 following Pseudomonas aeruginosa corneal infection. Investig. Ophthalmol. Vis. Sci. 36:1107-1114[Abstract/Free Full Text].
13. Hobden, J. A., S. A. Masinick, R. P. Barrett, and L. D. Hazlett. 1997. Proinflammatory cytokine deficiency and the pathogenesis of Pseudomonas aeruginosa keratitis in aged mice. Infect. Immun. 65:2754-2758[Abstract].
14. Kernacki, K. A., and R. S. Berk. 1995. Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa. Investig. Ophthalmol. Vis. Sci. 36:16-23[Abstract/Free Full Text].
15. O'Callaghan, R. J., L. S. Engel, J. A. Hobden, M. C. Callegan, L. C. Green, and J. M. Hill. 1996. Pseudomonas keratitis: the role of an uncharacterized exoprotein, protease IV, in corneal virulence. Investig. Ophthalmol. Vis. Sci. 37:534-543[Abstract/Free Full Text].
16. Preston, M. J., P. C. Seed, D. S. Toder, B. H. Iglewski, D. E. Ohman, J. K. Gustin, J. B. Goldberg, and G. B. Pier. 1997. Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections. Infect. Immun. 65:3086-3090[Abstract].
17. Richardson, K. C., L. Jarrett, and E. H. Finke. 1960. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol. 35:313-323[Medline].
18. Steuhl, K. P., G. Doring, A. Henni, H. J. Thiel, and K. Botzenhart. 1987. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Investig. Ophthalmol. Vis. Sci. 28:1559-1568[Abstract/Free Full Text].
19. Verdrengh, M., T. A. Springer, J. C. Gutierrez-Ramos, and A. Tarkowski. 1996. Role of intercellular adhesion molecule 1 in pathogenesis of staphylococcal arthritis and in host defense against staphylococcal bacteremia. Infect. Immun. 64:2804-2807[Abstract].
20. Xu, H., J. K. Bickford, E. Luther, C. Carpentino, F. Takei, and T. A. Springer. 1996. Characterization of murine intercellular adhesion molecule-2. J. Immunol. 156:4909-4914[Abstract].
21. Xu, H., J. A. Gonzalo, Y. St. Pierre, I. R. Williams, T. S. Kupper, R. S. Cotran, T. A. Springer, and J. C. Gutierrez-Ramos. 1994. Leukocytosis and resistance to septic shock in intercellular adhesion molecule-1 deficient mice. J. Exp. Med. 180:95-109[Abstract/Free Full Text].


Infection and Immunity, February 1999, p. 972-975, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Huang, L. C., Reins, R. Y., Gallo, R. L., McDermott, A. M. (2007). Cathelicidin-Deficient (Cnlp / ) Mice Show Increased Susceptibility to Pseudomonas aeruginosa Keratitis. IOVS 48: 4498-4508 [Abstract] [Full Text]  
  • Parks, Q. M., Hobden, J. A. (2005). Polyphosphate Kinase 1 and the Ocular Virulence of Pseudomonas aeruginosa. IOVS 46: 248-251 [Abstract] [Full Text]  
  • Khatri, S., Lass, J. H., Heinzel, F. P., Petroll, W. M., Gomez, J., Diaconu, E., Kalsow, C. M., Pearlman, E. (2002). Regulation of Endotoxin-Induced Keratitis by PECAM-1, MIP-2, and Toll-like Receptor 4. IOVS 43: 2278-2284 [Abstract] [Full Text]  
  • Huang, X., McClellan, S. A., Barrett, R. P., Hazlett, L. D. (2002). IL-18 Contributes to Host Resistance Against Infection with Pseudomonas aeruginosa Through Induction of IFN-{gamma} Production. J. Immunol. 168: 5756-5763 [Abstract] [Full Text]  
  • Ruan, X., Chodosh, J., Callegan, M. C., Booth, M. C., Lee, T. D., Kumar, P., Gilmore, M. S., Pereira, H. A. (2002). Corneal Expression of the Inflammatory Mediator CAP37. IOVS 43: 1414-1421 [Abstract] [Full Text]  
  • Pillar, C. M., Hobden, J. A. (2002). Pseudomonas aeruginosa Exotoxin A and Keratitis in Mice. IOVS 43: 1437-1444 [Abstract] [Full Text]  
  • Kernacki, K. A., Barrett, R. P, McClellan, S., Hazlett, L. D. (2001). MIP-1{alpha} regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection. J. Leukoc. Biol. 70: 911-919 [Abstract] [Full Text]  
  • Cole, N., Krockenberger, M., Bao, S., Beagley, K. W., Husband, A. J., Willcox, M. (2001). Effects of Exogenous Interleukin-6 during Pseudomonas aeruginosa Corneal Infection. Infect. Immun. 69: 4116-4119 [Abstract] [Full Text]  
  • Kaifi, J. T., Diaconu, E., Pearlman, E. (2001). Distinct Roles for PECAM-1, ICAM-1, and VCAM-1 in Recruitment of Neutrophils and Eosinophils to the Cornea in Ocular Onchocerciasis (River Blindness). J. Immunol. 166: 6795-6801 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hobden, J. A.
Right arrow Articles by Hazlett, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hobden, J. A.
Right arrow Articles by Hazlett, L. D.